Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation

Haematologica

Volumn 96, Issue 1, 2011, Pages 119-127

  Mueller, Regula J ^a   Stussi, Georg ^a,b   Yung, Gisella Puga ^a,c   Nikolic, Milica ^d   Soldini, Davide ^b   Halter, Jörg ^e   Meyer Monard, Sandrine ^e   Gratwohl, Alois ^e   Passweg, Jakob R ^f   Odermatt, Bernhard ^b   Schan, Urs ^b   Biedermann, Barbara C ^e   Seebach, Jörg D ^a,c  

^a Laboratory for Transplantation Immunology   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c University Hospital and Medical Faculty of Geneva   (Switzerland)

^d ETH ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Chimerism; Endothelial cell; Gvhd; Hematopoietic stem cell transplantation

Indexed keywords

BLOOD GROUP H ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW; CHILD; CHIMERA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DONOR; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; SCHOOL CHILD; SHORT TANDEM REPEAT; SKIN BIOPSY;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; CHIMERISM; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; ENDOTHELIUM, VASCULAR; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; TANDEM REPEAT SEQUENCES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 78650980451     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.030288     Document Type: Article

References (44)

1. Rovo A, Gratwohl A. Plasticity after allogeneic hematopoietic stem cell transplantation. Biol Chem. 2008;389(7):825-36.
2. Medawar PB. Transplantation of tissues and organs: introduction. Br Med Bull. 1965;21(2):97-9.
3. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001;357(9249):33-7.
4. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346(1):5-15.
5. Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, et al. Intragraft expression of recipient-type ABO blood group antigens: long-term follow- up and histological features after liver transplantation. Liver Transpl. 2005;11(5): 547-54.
6. Hove WR, van Hoek B, Bajema IM, Ringers J, van Krieken JH, Lagaaij EL. Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytes. Liver Transpl. 2003;9(6):552-6.
7. Fogt F, Beyser KH, Poremba C, Zimmerman RL, Khettry U, Ruschoff J. Recipientderived hepatocytes in liver transplants: a rare event in sex-mismatched transplants. Hepatology. 2002;36(1):173-6.
8. Xu W, Baelde HJ, Lagaaij EL, De Heer E, Paul LC, Bruijn JA. Endothelial cell chimerism after renal transplantation in a rat model. Transplantation. 2002;74(9): 1316-20.
9. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med. 2002;8(3):194-5.
10. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996;93(2):705-8.
11. Koopmans M, Kremer HI, Baelde HJ, Fernandes RJ, De Heer E, Bruijn JA, et al. Chimerism in kidneys, livers and hearts of normal women: implications for transplantation studies. Am J Transplant. 2005;5(6): 1495-502.
12. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al Dhalimy M, et al. Cell fusion is the principal source of bone-marrow- derived hepatocytes. Nature. 2003;422 (6934):897-901.
13. Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA. 2006;103(35):13156-61.
14. Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL, et al. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci USA. 2004;101(48):16891-6.
15. Kvasnicka HM, Wickenhauser C, Thiele J, Varus E, Hamm K, Beelen DW, et al. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia. Leuk Lymphoma. 2003;44(2):321-8.
16. Thiele J, Varus E, Wickenhauser C, Kvasnicka HM, Lorenzen J, Gramley F, et al. Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation. 2004;77(12):1902-5.
17. Murata H, Janin A, Leboeuf C, Soulier J, Gluckman E, Meignin V, et al. Donorderived cells and human graft-versus-host disease of the skin. Blood. 2007;109(6): 2663-5.
18. Willemze AJ, Bakker AC, von dem Borne PA, Bajema IM, Vossen JM. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stemcell transplant recipients. Transplantation. 2009;87(7):1096-101.
19. Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant. 2005;11(12):1006-13.
20. Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, et al. Impact of ABO-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica. 2008;93 (11):1686-93.
21. Ludajic K, Balavarca Y, Bickeboller H, Rosenmayr A, Fischer GF, Fae I, et al. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant. 2009;15(11):1400-6.
22. Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Xenotransplantation. 2006;13(2):126-32.
23. Le Pendu J, Caillard T, Mollicone R, Couillin P, Oriol R. Expression of ABH and X (Lex) antigens in various cells. Biochimie. 1988;70(11):1613-8.
24. Page C, Rose M, Yacoub M, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol. 1992;141(3):673-83.
25. Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder DA, Olson SB, et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood. 2004;103(1):13-9.
26. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res. 2004;94(2):230-8.
27. Tsuzuki M. Bone marrow-derived cells are not involved in reendothelialized endothelium as endothelial cells after simple endothelial denudation in mice. Basic Res Cardiol. 2009;104(5):601-11.
28. Perry TE, Song M, Despres DJ, Kim SM, San H, Yu ZX, et al. Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc Res. 2009;84(2):317-25.
29. Athanasou NA, Quinn J, Brenner MK, Prentice HG, Graham A, Taylor S, et al. Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation. Br J Cancer. 1990;61(3): 385-9.
30. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature. 1987;328(6129): 429-32.
31. Thiele J, Varus E, Wickenhauser C, Kvasnicka HM, Metz KA, Beelen DW. Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation. Histol Histopathol. 2004;19(1):201-9.
32. Suratt BT, Cool CD, Serls AE, Chen L, Varella-Garcia M, Shpall EJ, et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003;168(3):318-22.
33. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87(1):1-13.
34. Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359(9323):2078-83.
35. Brody JI, Beizer LH. Alteration of blood group antigens in leukemic lymphocytes. J Clin Invest. 1965;44:1582-9.
36. Bloom S, Fleming K, Chapman R, Neuberger J, Hubscher S. Inappropriate expression of blood group antigens in hepatic allografts. Hepatology. 1994;19(4): 876-81.
37. David L, Leitao D, Sobrinho-Simoes M, Bennett EP, White T, Mandel U, et al. Biosynthetic basis of incompatible histoblood group A antigen expression: anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Res. 1993;53(22):5494-500.
38. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005;11(3):261-2.
39. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, et al. Bone marrow- derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA. 2008;105(18): 6620-5.
40. Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int J Cancer. 2009;125(8):1771-7.
41. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001; 7(11):1194-201.
42. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, et al. Bone marrow- derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 2007;21(12): 1546-58.
43. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94(5):678-85.
44. Stussi G, West L, Cooper DK, Seebach JD. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplantation. 2006;13(5):390-9.